CRDL
Cardiol Therapeutics Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$2.20
+1.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.74x
- Price / sales
- —
- Price / cash flow
- -14.73x
Enterprise value
- Enterprise value
- $238.2M
- EV / sales
- —
- EV / EBITDA
- -8.91x
- EV / EBIT
- -8.37x
- Market cap
- $257.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026